Almirall S.A (ALM) | Stock Overview & Key Data
Almirall S.A. | Large-cap | Healthcare
Almirall S.A. | Large-cap | Healthcare
Almirall S.A Performance Comparison
Stock Range
Today's Range
Low: €11.34
High: €11.60
on September 23, 2025
52 Week Range
Low: €8.03
High: €11.66
on December 30, 2024
on September 22, 2025
All-Time High: €19.09 on December 28, 2015
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€2.5B
EPS
0.10
P/E Ratio (TTM)
116.00
Forward P/E
25.22
P/B Ratio
1.70
PEG Ratio
25.22
Div. Yield
1.67%
ROE
1.45%
Beta
0.340
Debt to Equity
26.47
Financial Highlights
Profitability
Gross Margin
91.07%
Operating Margin
3.22%
Profit Margin
2.02%
Returns and Earnings
Return on Assets (TTM)
1.56%
Return on Equity (TTM)
1.45%
EBITDA
€221.8M
Net Income (TTM)
€21.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€4.94
Quarterly Revenue Growth (YoY)
10.30%
Quarterly Earnings Growth (YoY)
-37.70%
Dividend Information
Last 12-Month Dividend
€0.18
Current Dividend Yield
1.67%
3-Year Average Dividend Yield
1.97%
3-Year Average Annual Dividend
€0.18
3-Year Total Dividends
€0.54
Ex-Dividend Date
May 15, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Almirall S.A ALM | 2.49B Large-cap | 3.76% | 3.57% | 9.23% | 14.51% | 38.42% | 31.07% | 17.65% | 20.08% |
| Laboratorios ROVI | 3.04B Large-cap | -1.84% | 1.82% | 8.89% | 11.79% | -8.13% | -18.56% | 33.03% | 89.68% |
| Faes Farma S.A FAE | 1.31B Large-cap | 0.47% | -0.24% | -6.19% | 20.11% | 20.80% | 14.29% | 14.29% | 26.19% |
| Laboratorio Reig RJF | 229.52M Mid-cap | -0.35% | -4.05% | -8.09% | 7.58% | 10.51% | 3.65% | 25.66% | -33.18% |
| Labiana Health S.A LAB | 28.89M Small-cap | 0.00% | 2.04% | 9.89% | 35.14% | 36.05% | 60.00% | 13,233.33% | 640.74% |
| Grifols, S.A GRF | 7.45B Large-cap | -0.83% | -3.95% | 17.57% | 29.60% | 25.90% | 17.34% | 34.12% | -52.40% |
Ownership & Short Interest
Insider Ownership
64.93%
Institutional Ownership
16.19%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
87K
Average 90-Day Volume
121K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALM's 52-week high and low?
- In the last 52 weeks, Almirall S.A reached a high of €11.66 (on September 22, 2025) and a low of €8.03 (on December 30, 2024).
- What is the market cap and P/E ratio for ALM?
- Curious about Almirall S.A's size and valuation? Its market capitalization stands at 2.49B. When it comes to valuation, the P/E ratio (trailing twelve months) is 116.00, and the forward P/E (looking ahead) is 25.22.
- Does ALM pay dividends? If so, what's the yield?
- Yes, Almirall S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.67%, and the company has paid an average of €0.18 per share annually over the past 3 years.
- Who are Almirall S.A's main competitors or similar companies to consider before investing?
When looking at Almirall S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI3.04B Healthcare Drug Manufacturers - Specialty & Generic -18.56% 33.03% Faes Farma S.A
FAE1.31B Healthcare Drug Manufacturers - Specialty & Generic 14.29% 14.29% Laboratorio Reig
RJF229.52M Healthcare Drug Manufacturers - Specialty & Generic 3.65% 25.66% Labiana Health S.A
LAB28.89M Healthcare Drug Manufacturers - Specialty & Generic 60.00% 13,233.33% Grifols, S.A
GRF7.45B Healthcare Drug Manufacturers - General 17.34% 34.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Almirall S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Almirall S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.45%, the Debt to Equity ratio from the most recent quarter is 26.47, and its Gross Profit Margin stands at 91.07%.
- What is the recent revenue and earnings growth for ALM?
- Looking at Almirall S.A's growth, its revenue over the trailing twelve months (TTM) was €1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.30%, and quarterly earnings saw a YoY growth of -37.70%.
- How much of ALM stock is held by insiders and institutions?
- Wondering who owns Almirall S.A stock? Company insiders (like executives and directors) hold about 64.93% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 16.19%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.